Ethosuximide induced agranulocytosis.
D000380:Agranulocytosis / Q000139:chemically induced*; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D004314:Down Syndrome / Q000188:drug therapy; D005013:Ethosuximide / Q000009:adverse effects* / Q000627:therapeutic use; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007223:Infant; D008297:Male
D000927:Anticonvulsants; D005013:Ethosuximide